Literature DB >> 23103331

Duration of membrane rupture and risk of perinatal transmission of HIV-1 in the era of combination antiretroviral therapy.

Amanda M Cotter1, Kathleen F Brookfield, Lunthita M Duthely, Victor H Gonzalez Quintero, JoNell E Potter, Mary J O'Sullivan.   

Abstract

OBJECTIVE: The objective of the study was to determine whether the duration of membrane rupture of 4 or more hours is a significant risk factor for perinatal transmission of human immunodeficiency virus (HIV) in the era of combination antiretroviral therapy (ART). STUDY
DESIGN: This was a prospective cohort study of 717 HIV-infected pregnant women-infant pairs with a delivery viral load available who received prenatal care and delivered at our institution during the interval 1996-2008.
RESULTS: The cohort comprised 707 women receiving ART who delivered during this interval. The perinatal transmission rate was 1% in women with membranes ruptured for less than 4 hours and 1.9% when ruptured for 4 or more hours. For 493 women with a delivery viral load less than 1000 copies/mL receiving combination ART in pregnancy, there were no cases of perinatal transmission identified up to 25 hours of membrane rupture. Logistic regression demonstrated only a viral load above 10,000 copies/mL as an independent risk factor for perinatal transmission.
CONCLUSION: Duration of membrane rupture of 4 or more hours is not a risk factor for perinatal transmission of HIV in women with a viral load less than 1000 copies/mL receiving combination ART.
Copyright © 2012 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23103331     DOI: 10.1016/j.ajog.2012.10.862

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  4 in total

1.  A novel molecular microbiologic technique for the rapid diagnosis of microbial invasion of the amniotic cavity and intra-amniotic infection in preterm labor with intact membranes.

Authors:  Roberto Romero; Jezid Miranda; Tinnakorn Chaiworapongsa; Piya Chaemsaithong; Francesca Gotsch; Zhong Dong; Ahmed I Ahmed; Bo Hyun Yoon; Sonia S Hassan; Chong Jai Kim; Steven J Korzeniewski; Lami Yeo
Journal:  Am J Reprod Immunol       Date:  2014-01-13       Impact factor: 3.886

2.  Most women living with HIV can deliver vaginally-National data from Finland 1993-2013.

Authors:  Inka Aho; Marja Kaijomaa; Pia Kivelä; Heljä-Marja Surcel; Jussi Sutinen; Oskari Heikinheimo
Journal:  PLoS One       Date:  2018-03-22       Impact factor: 3.240

3.  Thai national guidelines for the prevention of mother-to-child transmission of human immunodeficiency virus 2017.

Authors:  Rangsima Lolekha; Kulkanya Chokephaibulkit; Nittaya Phanuphak; Surasith Chaithongwongwatthana; Sasisopin Kiertiburanakul; Pleonchan Chetchotisakd; Sarawut Boonsuk
Journal:  Asian Biomed (Res Rev News)       Date:  2017-04

4.  HIV in pregnancy - An update.

Authors:  Victor N Chilaka; Justin C Konje
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2020-11-12       Impact factor: 2.435

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.